Dealmaking among private equity firms and in the sports and video games sectors has gone full steam ahead amid a global M&A freeze.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Goldman Sachs launched its ETF accelerator platform, intended to help smaller third-party funds enter the $10 trillion market.
Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.
Sam Bankman-Fried’s trial is shaping up to be one of the biggest show trials on Wall Street since Bernie Madoff. Did SBF’s parents know?
Coca-Cola was one of several companies whose earnings last week flashed positive signs, despite the hail of uncertainty around tariffs.
On Tuesday, the S&P 500 and the Nasdaq 100 both sank to their lowest respective levels in three months. What has investors so anxious?
Solaris was once a rising star in the fintech world. Now its sweating to raise 100 million euros to fund a major client project.
JPMorgan Chase may be looking past the current AI craze for optimization, setting it’s sights on quantum computing.
Top of the list is a warning over the rise of 24-hour trading, just as the Nasdaq and the New York Stock Exchange pursue it.
The volume of options trading, especially short-dated deals, has skyrocketed thanks to amateur investors lured by new trading apps.
Buffett acolytes are primed to be receptive to new ideas after Berkshire’s more contrarian bets over the last decade have proven prescient.
Tariff-induced uncertainty and related market jitters stalled what was expected to be a rebound year for mergers and acquisitions.
When yields rise, it suggests a selloff, and it also means likely higher costs of borrowing for companies as well as the government.
Traders betting against SPY, an exchange traded fund that tracks S&P 500 stocks, racked up more than $6 billion in profits this month.